Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety
A Standard patent application filed on 25 November 1997 credited to Baker, Raymond ; Curtis, Neil Roy ; Elliott, Jason Matthew ; Harrison, Timothy ; Hollingworth, Gregory John ; Williams, Brian John ; Kulagowski, Janusz Jozef ; Rupniak, Nadia Melanie ; Seward, Eileen Mary ; Swain, Christopher John ; Jackson, Philip Stephen

Details

Application number :

55591  

Application type :

Standard  

Application status :

CEASED  

Under opposition :

No  

Proceeding type :

 

Invention title :

Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety  

Inventor :

Baker, Raymond ; Curtis, Neil Roy ; Elliott, Jason Matthew ; Harrison, Timothy ; Hollingworth, Gregory John ; Williams, Brian John ; Kulagowski, Janusz Jozef ; Rupniak, Nadia Melanie ; Seward, Eileen Mary ; Swain, Christopher John ; Jackson, Philip Stephen  

Agent name :

SPRUSON & FERGUSON  

Address for service :

GPO Box 3898 SYDNEY NSW 2001  

Filing date :

25 November 1997  

Associated companies :

 

Applicant name :

Merck Sharp & Dohme Limited  

Applicant address :

Hertford Road Hoddesdon Hertfordshire EN11 9BU United Kingdom  

Old name :

 

Original Source :

Go  

Same Inventor

• Use of NK-1 receptor antagonists for treating sexual dysfunctions
• Use of NK-1 receptor antagonists for treating major depressive...
• Use of NK-1 receptor antagonists for treating stress disorders
• Use of NK-1 receptor antagonists for treating bipolar disorders
• Use of NK-1 receptor antagonists for treating substance use disorders